InvestorsHub Logo
Followers 0
Posts 139
Boards Moderated 0
Alias Born 06/08/2010

Re: poweredbyfuse post# 987

Wednesday, 06/13/2012 3:58:18 PM

Wednesday, June 13, 2012 3:58:18 PM

Post# of 2931
FDA will not designate an Orphan Drug status and waive the hefty prescription drug application user fee of $1M+ (in addition to other benefits to RGIN) if the product does no meet safety and efficacy standards to begin with. The article is twisted. RGIN is right on.